Edge Therapeutics Inc. | Mutual Funds
Mutual Funds that own Edge Therapeutics Inc.
Janus Capital Funds Plc - Global Life Sciences Fund
596,362
1.91%
-23,566
0.02%
12/31/2017
Vanguard Total Stock Market Index Fund
532,519
1.7%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
294,157
0.94%
0
0%
07/31/2018
Pictet - Biotech
185,885
0.6%
185,885
0.01%
03/31/2018
143,832
0.46%
-16,821
0.03%
01/23/2018
Fidelity Nasdaq Composite Index
94,051
0.3%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
91,361
0.28%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
50,398
0.16%
0
0%
07/31/2018
iShares Micro Cap ETF
48,576
0.16%
0
0%
09/06/2018
Vanguard Growth & Income Fund
41,800
0.13%
38,300
0%
06/30/2018
| Address |
300 Connell Drive
Berkeley Heights New Jersey 07922
United States
|
|
Employees
|
- |
| Website |
http://www.edgetherapeutics.com |
| Updated |
09/14/2018 |
| Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. |
